Skip to main content

Month: May 2020

Pipestone Energy Corp. to Reschedule Shareholder Meeting

CALGARY, Alberta, May 25, 2020 (GLOBE NEWSWIRE) — (PIPE – TSX-V) Pipestone Energy Corp. (“Pipestone Energy” or the “Company”) announces that it is cancelling the annual and special meeting of shareholders scheduled for June 30, 2020. Once the situation in Alberta has improved such that an in-person meeting can be held in a manner that is safe for the participants, Pipestone Energy will reschedule and hold an annual and special meeting of shareholders.Pipestone Energy will rely on the temporary blanket relief provided by the Canadian Securities Administrators, including exemptive  relief  contained  in Alberta Securities Commission Blanket Order 51-518 – Temporary  Exemptions  from  Certain Requirements to File or Send Securityholder Materials, and will postpone the public filing of its executive compensation disclosure required...

Continue reading

Partners Value Investments Inc. Announces Q1 2020 Interim Results

TORONTO, May 25, 2020 (GLOBE NEWSWIRE) — Partners Value Investments Inc. (the “Company”, TSX: PVF.WT) announced today its financial results for the three months ended March 31, 2020. All amounts are stated in US dollars.The Company generated net income of $170 million for the three months ended March 31, 2020 compared to net loss of $61 million in the prior year period. The increase in net income was primarily driven by foreign currency gains on our CAD denominated preferred shares and a decrease in warrant liability as a result of the change in market price of Partners Value Investments L.P.The market price of a Brookfield share on a post-split basis was $29.50 as at March 31, 2020 (December 31, 2019 – $38.53). Brookfield completed a three-for-two stock split on April 1, 2020.Consolidated Statements of Operations

Continue reading

Partners Value Investments L.P. Announces 2020 First Quarter Results

TORONTO, May 25, 2020 (GLOBE NEWSWIRE) — Partners Value Investments L.P. (the “Partnership” TSX: PVF.UN TSX:PVF.PR.U) announced today its financial results for the three months ended March 31, 2020. All amounts are stated in US dollars.The Partnership generated net income of $74 million for the quarter ended March 31, 2020 compared to $29 million in the prior year period. The increase in net income was primarily attributable to foreign currency gains recognized during the quarter.The market price of a Brookfield share was $29.50 per share at March 31, 2020 compared to $38.53 at December 31, 2019, adjusted for the three-for-two stock split effective April 1, 2020.Consolidated Statements of Operations

Continue reading

Coloplast A/S – Transactions in connection with share buy-back programme, week 21

As mentioned in Announcement no. 02/2020 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.The programme will commence on 24 February 2020 and is expected to end by 24 August 2020.The share buyback programme is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations with the purpose of meeting obligations arising from share options programmes or other allocation of shares to employees or to complete a share capital decrease as set out in Articles 5(2)(a) and 5(2)(c) in MAR.The following transactions have been executed during the period 18 – 20 May 2020:Henceforth, Coloplast owns 3,237,227 treasury B shares of DKK 1 equal to 1,50%...

Continue reading

Coloplast A/S – Transaktioner i henhold til aktietilbagekøbsprogram, uge 21

Som meddelt i Selskabsmeddelelse nr. 02/2020 har Coloplast iværksat et tilbagekøbsprogram på i alt 500 millioner kroner. Programmet begyndte den 24. februar 2020 og forventes afsluttet den 24. august 2020.Aktietilbagekøbsprogrammet struktureres i henhold til bestemmelserne i artikel 5 i EU-Parlamentet og Rådets forordning nr. 596/2014 af 16. april 2014 (MAR) og forordning 2016/1052, også kaldet ”Safe Harbour” reglerne, med det formål at opfylde forpligtelser i henhold til aktieoptionsprogrammer eller andre aktieallokeringer til medarbejdere eller at gennemføre en kapitalnedsættelse i henhold til artikel 5(2)(a) og artikel 5(2)(c) i MAR.                      I perioden 18. – 20. maj 2020 er der foretaget følgende køb:Coloplast ejer herefter 3.237.227 egne B-aktier à DKK 1 svarende til 1,50% af selskabets samlede aktiekapital.Separat oversigt...

Continue reading

Eik fasteignafélag hf.: Krafa um margfeldiskosningu

Stjórn Eikar fasteignafélags hf. hefur borist krafa frá Brimgörðum ehf. um að beitt verði margfeldiskosningu við kjör stjórnar félagsins sem fram fer á aðalfundi 10. júní 2020. Krafan var send til stjórnar innan tilskilins frests og barst frá hluthafa sem hefur yfir að ráða meira en 1/50 hluta hlutafjár, sbr. 5. mgr. 20. gr. samþykkta félagsins. Margfeldiskosningu verður því beitt við stjórnarkjörið.Margfeldiskosning fer fram með eftirfarandi hætti: Kosið skal á milli einstaklinga. Gildi hvers atkvæðis skal margfaldað með fjölda þeirra stjórnarmanna sem kjósa skal og má hluthafi skipta atkvæðamagni sínu, þannig reiknuðu, í hverjum þeim hlutföllum, sem hann sjálfur kýs, á jafnmarga menn og kjósa skal eða færri. Ef ekki er á atkvæðaseðli getið skiptingar atkvæða á milli þeirra sem þau eru greidd skal þeim skipt að jöfnu.

Continue reading

Auriant Mining Q1 2020 Interim Report and Online Conference, May 29th 2020

Auriant Mining AB is pleased to announce that the Company’s Q1 2020 interim report will be published on Friday, May 29th.This will be followed by an interactive webcast for analysts and investors with the CEO, Sergey Ustimenko who will be presenting Auriant Mining’s Q1 2020 results as well as hosting a Q&A session.The event will begin at 13:00 CET (13:00 Stockholm, 14:00 Moscow, 12:00 London).Those who wish to receive an email reminder an hour before the event can pre-register using the link or open the link directly to participate in Online Conference on Friday, May 29th:Link to register on Q1 2020 Interim Report Online ConferenceFor more information, please contact:Sergey Ustimenko, CEOTel: +7 495 109 02 82E-mail: sergey.ustimenko@auriant.comCompany name: Auriant Mining ABShort name: AURISIN-code: SE0001337213Website: www.auriant.comwww.facebook.com/AuriantMining/Auriant...

Continue reading

Auriant Mining:s delårsrapport för Q1 2020 och online-konferens den 29 maj 2020

Auriant Mining AB har nöjet att meddela att Bolagets delårsrapport för Q1 2020 kommer att publiceras på fredagen den 29 maj.Detta kommer att följas av en interaktiv webcast för analytiker och investerare med vd Sergey Ustimenko som kommer att presentera Auriant Mining:s resultat för Q1 2020 samt med en möjlighet att ställa frågor.Evenemanget börjar kl. 13:00 CET (13:00 Stockholm, 14:00 Moskva, 12:00 London).De som vill få en e-postpåminnelse en timme innan evenemanget kan registrera sig genom länken eller öppna följande länk direkt för att delta i online-konferensen fredagen den 29 maj:Link to register on Q1 2020 Interim Report Online ConferenceFör mer information, vänligen kontakta:Sergey Ustimenko, VDTel: +7 495 109 02 82E-post: sergey.ustimenko@auriant.comFöretagsnamn: Auriant Mining ABKortnamn: AURISIN-kod: SE0001337213Website: www.auriant.comwww.facebook.com/AuriantMining/Auriant...

Continue reading

Hofseth Biocare ASA: Completed Annual General Meeting

The AGM in Hofseth BioCare ASA were held in Havnegata 11, Ålesund today on Monday 25 May 2020. All the matters were decided according to the proposals in the notice. Please find the minutes from the AGM attached.For further information, please contact:Jon Olav Ødegård, CFO of Hofseth BioCare ASAPhone: +47 936 32 966E-mail: joo@hofsethbiocare.noAbout Hofseth BioCare ASA:HBC is a Norwegian biotech company that develops high-value ingredients and finished products. The ingredients are in various stages of discovery and preclinical development in collaboration with multiple clinics and university research labs in several countries. Lead preclinical and clinical candidates are in development toward treatment for iron-deficiency anemia, gastro-Intestinal Inflammation (NEC/IBS/UC), prediabetes, age-related sarcopenia and osteoarthritis.The company...

Continue reading

Ress Life Investments AS Half-Year Report – 1 October 2019 – 31 March 2020

Copenhagen, 25 May 2020The Board of Directors and Management have today discussed and approved the Half-Year Report of Ress Life Investments A/S for the period 1 October 2019 – 31 March 2020:Ress Life Investments A/S realised a net profit before and after tax of USD 3,638,925 for the period 1 October 2019 – 31 March 2020. The net profit for the period corresponds to a net return on equity of 1.99%, earnings per share at 40.60 and an increase in net asset value of USD 42.01 per share.The increase in profit before tax mainly relates to positive fair value adjustments offset by administrative expenses and staff costs.The fair value of the Company’s investment assets increased from USD 118,791,752 at 30 September 2019 to USD 159,631,723 at 31 March 2020.Equity stands at USD 182,699,386 as of 31 March 2020, corresponding to a net asset value...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.